Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.
about
Molecular characterisation of plasma membrane-derived vesiclesHandling and storage of human body fluids for analysis of extracellular vesicles.Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.Increased promyelocytic-derived microparticles: a novel potential factor for coagulopathy in acute promyelocytic leukemia.Microparticles as biomarkers of osteonecrosis of the hip in sickle cell diseaseProduction, fate and pathogenicity of plasma microparticles in murine cerebral malaria.Excess of heme induces tissue factor-dependent activation of coagulation in mice.Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulationIntroduction to haemostasis from a pharmacodynamic perspectiveIsolation and phenotypic characteristics of microparticles in acute respiratory distress syndrome.Circulating membrane-derived microvesicles in redox biology.Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceDifferences of microparticle patterns between sickle cell anemia and hemoglobin SC patients.Microvesicle phenotypes are associated with transfusion requirements and mortality in subjects with severe injuriesThe Impact of Lipoprotein-Associated Oxidative Stress on Cell-Specific Microvesicle Release in Patients with Familial Hypercholesterolemia.Coagulation activation in sickle cell trait: an exploratory studyFetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemiaMicroparticles variability in fresh frozen plasma: preparation protocol and storage time effects.Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.Microvesicles: potential markers and mediators of endothelial dysfunction.Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia.Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients.Towards traceable size determination of extracellular vesicles.Clinical CVVH model removes endothelium-derived microparticles from circulation.Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeuticsMicroparticles in stored red blood cells: submicron clotting bombs?Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis.Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions?Potential role for statins in sickle cell disease.Extracellular vesicles in the circulation: are erythrocyte microvesicles a confounder in the plasma haemoglobin assay?Interplay between coagulation and vascular inflammation in sickle cell disease.Red blood cell microparticles: clinical relevance.Revisited role of microparticles in arterial and venous thrombosis.
P2860
Q26799753-41FD9BAA-A60D-4186-A3A9-7EEC1E42B097Q30396432-D9CA7575-06F2-44EA-968C-3EFF73F165D3Q33803027-144E36C1-36B3-4543-9C63-2184CFF07DA7Q34560286-966B30A4-9422-4D4E-B57B-1A1FB9A922E2Q34674505-C89E4C0C-2EC1-4901-AE14-50DBAC1DF736Q35126111-A93C0C35-FA6D-4CE7-BCAB-465411B7B375Q35146268-E5FEEE14-7E47-4F2A-BA7C-52D6E26DEBABQ35227861-F02583DE-2B36-423C-95B7-F7C12DEDE9AFQ35373597-849DA8DE-59F7-4573-8B8C-1803F916D622Q35631232-5FBB14E9-C13F-42F8-99A0-062C7F541902Q35737756-562D8097-0D4E-479E-87B8-7D7E6B47D526Q35754765-C779E55C-AAD2-47B6-9498-FA86DA275D81Q35813199-294EEC3D-87BD-495E-A4AA-25D19A0091BAQ35881838-B479C4F6-4D24-4767-BBB2-333C46EA0565Q35949830-32ECE794-F65F-4D28-82A3-336B5A48F680Q36143261-2FCCF564-5022-4170-89ED-91F2FB6DE0D0Q36368068-F9557E01-3C0C-4A9D-AC72-438D49406EEAQ36388098-7BD77E7C-192B-4781-A25E-3CF20F00BF84Q36564652-5EC9850D-0D38-497F-95B2-035AE3C9E2B7Q36661960-94B500BA-704E-4693-8620-B91DB100988CQ36892578-26EA1A56-DE9A-4AA6-9A53-1D1666D10506Q36909379-B55692D9-CB96-4F90-935C-4FDE48F7DD1FQ37032283-6B1148A0-FE05-466C-AB79-C0F613C50F41Q37033939-E0DED9C4-3CFD-4583-8025-3523C08CF11EQ37273154-4FC7C247-4A24-4FB1-99FC-5A62460D7A6EQ37295504-014DBAEE-3588-4185-A612-F0514690A34DQ37514497-AABD0CBA-A904-47E1-B8C6-2906A8AA7072Q37539000-D6CA6070-2E27-4690-8BCB-50B9F75B3EA6Q37563988-3853DA08-232E-4BFB-9DE1-B3E37FC6359CQ37610439-665B1147-F0FF-46AE-B9B6-79C941EC4261Q37700095-3714CC0D-9D3B-4CC7-AE5F-775BB5402582Q37770410-188C9624-E8EC-4940-A327-B8F4CDA82216Q37872265-5795A5DB-582A-40BA-8BDC-CA487D94B6F7Q37922118-1C05AEC5-02D3-4A4A-A73D-6312E3B5768BQ38034393-19808E22-38D0-4DD2-AD03-70058713DA7FQ38071047-D0D12C40-6355-4AB5-A67A-F907DA1ECFA6Q38077243-E3398472-9F3B-45A7-A13F-FC6A067D8CD4Q38099667-6A087C50-0DA4-4F69-ACBE-135A2D8EAC62Q38117133-E82B2ADA-1DC5-4B25-9F0A-E8E5298C3286Q38117725-39BC633B-DFF2-4D0A-ADD1-33A74CBAA520
P2860
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@en
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@nl
type
label
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@en
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@nl
prefLabel
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@en
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@nl
P2093
P2860
P1433
P1476
Circulating erythrocyte-derive ...... vation in sickle cell disease.
@en
P2093
Augueste Sturk
Bart J Biemond
CURAMA study group
Frederiek F van Doormaal
Joost C M Meijers
Marianne C L Schaap
René J Berckmans
P2860
P304
P356
10.3324/HAEMATOL.2009.008938
P577
2009-10-08T00:00:00Z